New developments in thrombosis therapy.
Researchers presenting at the 16th International Congress on Thrombosis (Mediterranean League against Thromboembolic Disease), held May 58, 2000, in Porto, Portugal, reviewed the latest developments in the treatment of thrombosis. Several symposia focused attention on the new indications for low-molecular-weight heparins and provided updates on trials. The roles of tissue factor and tissue factor pathway inhibitor were extensively reviewed, and a number of late-stage developmental anticoagulants were presented.